OpenAI targets drug discovery with new AI model

OpenAI is introducing an early-stage artificial intelligence model specifically designed to accelerate the complex process of drug discovery. This move places OpenAI among other technology firms actively exploring AI's potential to drive significant breakthroughs in scientific research. The development signifies a growing trend of applying advanced AI capabilities beyond general applications to specialized fields like life sciences, aiming to solve intricate problems and expedite innovation.